FDA approves pocket sized osteoporosis diagnostic device

Most doctors will likely order a bone density x-ray scan for patients at risk of osteoporosis, and not only is that an expensive method but it also requires a physician referral. Now, the FDA has cleared a pocket-sized osteoporosis diagnosis device that might help physicians make the process of diagnosing the disease a bit easier.

Bindex, measures the cortical bone thickness of the tibia and an algorithm calculates the Density Index. The company who created the device, Bone Index, says that the detection rate is 90 percent and will ultimately increase efficiency with physicians.

"The clearance process with the FDA was straightforward despite the novel approach introduced with Bindex. The technique is based on extensive clinical evidence, and with the effectiveness of Bindex, the current care of osteoporosis can be significantly improved," said Bone Index's CTO and Founder Janne Karjalainen, PhD, in a statement.

In a recent article published in Osteoporosis International, the company cited that by combining the Bindex test and the international fracture risk calculator (FRAX), physicians would also be able to provide results for patients who need medication.

“This is extremely important because an estimated 75 percent of osteoporosis sufferers are undiagnosed and without the treatment they need," said Partner Heikki Kröger, MD, PhD, professor at the Kuopio University Hospital in Joensuu, Finland.

Jodelle joined TriMed Media Group in 2016 as a senior writer, focusing on content for Radiology Business and Health Imaging. After receiving her master's from DePaul University, she worked as a news reporter and communications specialist.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup